6.5 C
New York
Wednesday, June 16, 2021

Iran could acquire nuclear weapon in two years: French FM

Must Read

Kamal Saini
Kamal S. has been Journalist and Writer for Business, Hardware and Gadgets at Revyuh.com since 2018. He deals with B2b, Funding, Blockchain, Law, IT security, privacy, surveillance, digital self-defense and network policy. As part of his studies of political science, sociology and law, he researched the impact of technology on human coexistence. Email: kamal (at) revyuh (dot) com

Iran could acquire nuclear weapons in one to two years if it continues to violate the 2015 agreement on its nuclear program, the French Foreign Minister Jean-Yves Le Drian said today.

“If they continue to dismantle the Vienna Agreement, then yes, within a relatively short period of time, between one and two years, they may have access to a nuclear weapon,” Le Drian told RTL radio station.

EU foreign ministers are meeting urgently today to find ways to move the United States and Iran out of a confrontation, knowing that a miscalculation by either side could bring the European Union into a war and a serious crisis of dissemination and nuclear weapons in their backyard.

The French foreign minister also added that his country intends to contribute to the investigation into the Ukrainian passenger jet that crashed in Iran on Wednesday.

“France intends to contribute” to the investigation, Le Drian noted, noting that the Iranian authorities have not yet been asked to do so.

Iran’s spokesman for the International Civil Aviation Organization Farhad Parvares said yesterday that France may also be involved in the investigation given that the Boeing machine maker is partly a French company (CFM is a joint venture of US General Electric and Safran).

“Before we take a position, it is important to have as much clarity as possible about what happened,” Le Drian said, speaking to RTL.

- Advertisement -
- Advertisement -

Latest News

Alzheimer’s Vaccine May Be Closer Than We Think

A new experimental vaccine to treat Alzheimer's disease has successfully passed its last phase of human testing. The drug, whose...
- Advertisement -

More Articles Like This

- Advertisement -